NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MyfoA.00921.a: 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase (Rv3606c ortholog)

Target Characteristics

from organism: Mycobacterium fortuitum ATCC 6841 / DSM 46621
most recent status: purified
center reference id: MyfoA.00921.a
is community request: True
associated disease:
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MyfoA.00921.a.B1.GE37904 full length 1 178 GE37904
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

Proteins

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MyfoA.00921.a.B1.PW37497 full length 1 178

External Resources

Resource Reference ID
PATRIC ID: fig|1214102.3.peg.5880
RefSeq: WP_003882537.1
UniProt: K0UD01

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MTSTVLSIGS NIGDRLARLQ SVVDGLGTAV RAVSPVFETD AWGGVEQSPF LNAVLLADDP GLDCHGWLRR GQQLEQEADR VREQKWGPRT LDVDLVTCHD GDVEVISRDE VLTLPHPLAH LRAFVLIPWL AVDPDATLTV VGRTRRVAHL LEEIDPAERA GVRPTDLALD FRAEPAGD

NT Sequence
gtgacttcca cggtgctctc gatcgggtcg aacatcggcg accggctggc ccggttgcag tcggtggtcg acggtctcgg aaccgccgtt cgcgcggtgt cgccggtgtt cgagaccgac gcctggggtg gagtcgagca gagtccgttc ctgaacgcgg tactgctcgc cgacgatccg ggcctggatt gccacggctg gctgcgccgc ggccagcagc tcgagcagga agccgatcgg gtccgggagc agaagtgggg cccgcgcacc ctcgacgtcg acctggtcac ctgccacgac ggtgacgtgg aggtgatttc ccgcgacgaa gttctgacgc tgccgcatcc gctggcccac ctgcgcgctt tcgttctcat cccgtggctg gcggtggacc cggacgccac cctgacggtc gtcggccgga cacggcgggt ggcgcatctg ctcgaggaga tcgacccggc cgaacgggcc ggggtcaggc ccaccgatct ggcgctggat ttccgcgcag aaccggcggg cgactga

© 2020 Seattle Children's Research Institute. All rights reserved.